Healthcare Finance News August 23, 2023
On or before September 1, CMS will release the names of the 10 Part D drugs subject to negotiated prices starting in 2026.
On or before September 1, the Centers for Medicare and Medicaid Services will release the names of the 10 Part D drugs subject to negotiated prices in Medicare starting in 2026.
This the first time the federal government is negotiating drug prices with pharmaceutical manufacturers, a move PhRMA and other opponents say should be more accurately called mandatory price controls.
The move is being allowed under the Inflation Reduction Act, which was signed into law on August 16, 2022.
The list is expected to drop any day, but no later than September 1, according to John...
Today's Sponsors
Today's Sponsor